Drug intelligence / Profile preview

ethinylestradiol + cyproterone + Selmevit

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination product consisting of ethinylestradiol, cyproterone, and Selmevit. Ethinylestradiol is a synthetic estrogen that acts as an agonist at the estrogen receptor, commonly used in hormonal contraceptives and for the treatment of various hormone-related disorders. Cyproterone is an antiandrogen and progestogen that acts as an antagonist at the androgen receptor and as an agonist at the progesterone receptor; it is used to treat conditions like acne, hirsutism, and androgen-dependent disorders. Selmevit is a multivitamin-multimineral complex containing vitamins (A, C, E, B1, B2, B6, B12), minerals (selenium, zinc, iron), antioxidants (rutin), amino acids (methionine), lipoic acid and other micronutrients[1][6][8]. The combination would theoretically provide both hormonal therapy effects from ethinylestradiol plus cyproterone and nutritional support from Selmevit.

02

Targets

PR (Progesterone receptor)ER (Estrogen receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on ethinylestradiol + cyproterone + Selmevit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethinylestradiol + cyproterone + Selmevit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call